Kidney Outcome Registry using AlloSeq dd-cfDNA (KORAD) v1.1

• Research type

  Research Study

• Full title

  Assessment of donor derived cell free DNA in renal and pancreas transplantation

• IRAS ID

  255433

• Contact name

  Natalia Diaz Burlinson

• Contact email

  Natalia.DiazBurlinson@mft.nhs.uk

• Sponsor organisation

  Manchester University NHS Foundation Trust

• Duration of Study in the UK

  1 years, 0 months, 1 days

• Research summary

  This study is a feasibility study of a new test - AlloSeq cfDNA - that will assess the amount of DNA present from a transplanted kidney or pancreas detected in the patient's blood. The test results will be compared to current tests such as antibody and biopsy to see if the transplanted organ is being damaged and rejected.

• REC name

  North West - Preston Research Ethics Committee

• REC reference

  21/NW/0270

• Date of REC Opinion

  23 Nov 2021

• REC opinion

  Further Information Favourable Opinion